Organigram Global(NASDAQ) OGI

Market Cap$132.10M

Since IPO (2014)-89%

5 Year-91%

1 Year-29%

1 Month-5%

$0.96

+3.7%

+0.03Today

Organigram Global last closing stock price
Metric	Price	Date
Last close	USD 0.97	2026-07-30

Organigram Global stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+5.26%	USD 0.92	2026-07-23
1 month	-5.1%	USD 1.02	2026-06-30
3 month	-31.83%	USD 1.42	2026-05-01
Year to date	-42.38%	USD 1.68	2025-12-31
1 year	-29.34%	USD 1.37	2025-07-30
3 year	-36.32%	USD 1.52	2023-07-31
5 year	-90.76%	USD 10.48	2021-07-30
Since inception	-88.75%	USD 8.61	2014-08-27

Organigram Global Financials at a Glance

Market Cap

$132.10M

Revenue (TTM)

CA$274.13M

Net Income (TTM)

-CA$25.23M

EPS (TTM)

-$0.14

P/E Ratio

-6.99

Dividend

$0.00

Beta (Volatility)

1.52 (High)

Dividend

$0.00

Beta (Volatility)

1.52 (High)

Price

$0.96

Volume

310,140.487

Open

$0.93

Price

$0.96

Volume

310,140.487

Open

$0.93

Previous Close

$0.97

Daily Range

$0.91 - $0.97

52-Week Range

$0.85 - $2.24

Estimated Earnings Date

Aug 11, 2026

Dividend

$0.00

Beta (Volatility)

1.52 (High)

Price

$0.96

Volume

310,140.487

Open

$0.93

Previous Close

$0.97

Daily Range

$0.91 - $0.97

52-Week Range

$0.85 - $2.24

Estimated Earnings Date

Aug 11, 2026

OGI News

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Organigram Global

Organigram Global Inc. is a Canadian company focused on the cultivation, production, and distribution of cannabis and related products. The company serves both the medical and recreational cannabis markets, offering a diverse range of products to consumers and retailers.

Products and Services

Medical cannabis products including flowers, oils, and vaporizing devices
Recreational cannabis offerings such as edibles and concentrates
Wholesale distribution of cannabis plant cuttings and pre-rolled products

Growth Outlook

Recent quarterly revenue reached CAD 59.79 million, indicating strong market demand
Gross profit margin improved to 27.4% in the latest quarter
Expansion into new markets is anticipated to drive future revenue growth

Financial Highlights

Trailing twelve months (TTM) revenue of CAD 234.5 million
Current ratio of 2.82 suggests strong liquidity position
Net income for Q1 2026 was CAD 19.97 million, showcasing profitability

Organigram Global Inc. operates in the rapidly growing cannabis industry, with a focus on both medical and recreational markets. The company has established a strong brand presence through its diverse product offerings, which include well-known brands like Edison Cannabis Co. and SHRED. Recent financial performance indicates a positive trajectory, with significant revenue growth and improved gross profit margins. The company's liquidity position is robust, as evidenced by a current ratio of 2.82, allowing for flexibility in operations and potential expansion initiatives. As the cannabis market continues to evolve, Organigram is well-positioned to capitalize on emerging opportunities, making it an intriguing option for potential investors.

AI Generated • Jul 19, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

1,139

CEO

James Hideo Yamanaka, MBA

Website

www.organigram.ca

Headquarters

Toronto, ON M5H 1J8, CA

OGI Financials

Key Financial Metrics (TTM)

Gross Margin

-3.07%

Operating Margin

-38.62%

Net Income Margin

-9.19%

Return on Equity

-6.83%

Return on Capital

-17.72%

Return on Assets

-4.84%

Earnings Yield

-14.31%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$132.10M

Shares Outstanding

136.47M

Volume

310.14K

Avg. Volume

563.52K

Financials (TTM)

Gross Profit

CA$97.71M

Operating Income

-CA$14.13M

EBITDA

CA$5.64M

Operating Cash Flow

-CA$8.65M

Capital Expenditure

-CA$11.41M

Free Cash Flow

-CA$20.06M

Cash & ST Invst.

CA$54.90M

Total Debt

CA$8.22M

Organigram Global Performance Analysis

Organigram Global annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-08-31	CAD 114,623,865	83.8%
2023	2023-09-30	CAD 110,622,912	-3.5%
2024	2024-09-30	CAD 117,459,865	6.2%
2025	2025-09-30	CAD 185,377,620	57.8%

Organigram Global sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-06-30	7.9%
Q4	2025-09-30	13.1%
Q1	2025-12-31	-20.7%
Q2	2026-03-31	-5.8%

Organigram Global annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-08-31	CAD -0.15	-91.0%
2023	2023-09-30	CAD -2.09	1339.4%
2024	2024-09-30	CAD -0.35	-83.3%
2025	2025-09-30	CAD -0.14	-60.4%

Organigram Global sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-06-30	-114.7%
Q4	2025-09-30	-495.7%
Q1	2025-12-31	153.6%
Q2	2026-03-31	-104.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

CA$59.79M

-8.9%

Gross Profit

CA$16.41M

-10.9%

Gross Margin

27.44%

N/A

Market Cap

$132.10M

N/A

Market Cap/Employee

$115.98K

N/A

Employees

1,139

N/A

Net Income

-CA$921.00K

-102.2%

EBITDA

-CA$4.76M

-73.5%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

CA$54.90M

+290.6%

Total Debt

CA$8.22M

-13.8%

Accounts Receivable

CA$53.53M

+7.1%

Inventory

CA$135.51M

+17.8%

Long Term Debt

CA$7.26M

-11.8%

Short Term Debt

CA$959.47K

-26.5%

Return on Assets

-4.84%

N/A

Return on Invested Capital

-24.48%

N/A

Free Cash Flow

-CA$6.54M

+71.7%

Operating Cash Flow

-CA$6.32M

+61.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LFCRLifecore Biomedical, Inc.

LFCRLifecore Biomedical, Inc.$4.36+0.93%

HSDTSolana Company

HSDTSolana Company$1.70+3.03%

ACBAurora Cannabis Inc.

ACBAurora Cannabis Inc.$2.83+3.66%

DERMJourney Medical Corporation

DERMJourney Medical Corporation$6.45+4.88%

RNACCartesian Therapeutics, Inc.

RNACCartesian Therapeutics, Inc.$7.73+4.18%

OBIOOrchestra BioMed Holdings, Inc.

OBIOOrchestra BioMed Holdings, Inc.$3.99+5.00%

IVAInventiva S.A.

IVAInventiva S.A.$4.62+2.44%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$91.13+0.11%

NVDANvidia

NVDANvidia$195.04+0.03%

MSFTMicrosoft

MSFTMicrosoft$451.10+0.16%

NOKNokia

NOKNokia$9.09+0.08%

AMZNAmazon

AMZNAmazon$235.50+0.04%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.21+0.07%

MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares

MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares$26.97+0.37%

Questions About OGI

What is the current price of Organigram Global?

Organigram Global is trading at $0.97 per share.

What is the 52-week range for Organigram Global?

Over the past 52 weeks, Organigram Global has traded between $0.85 and $2.24.

How much debt does Organigram Global have?

As of the most recent reporting period, Organigram Global reported total debt of CA$5.87M.

How much cash does Organigram Global have on hand?

Organigram Global reported CA$38.65M in cash and cash equivalents in its most recent financial results.

What is Organigram Global’s dividend yield?

Organigram Global does not currently have a dividend yield.

Organigram Global(NASDAQ) OGI

Organigram Global Financials at a Glance

OGI News

Best Cannabis ETFs to Buy in 2026 and How to Invest

Why Organigram Holdings Stock Is Perking Up Today

3 Top Cannabis Stocks to Buy for December

2 Pot Stocks That Could Set You Up for Life

1 Dynamic Growth Stock for September

This Cannabis Company Just Reported 90% Revenue Growth: Is It a Buy?

This Cannabis Company Just Pulled Off a Miracle

Why OrganiGram Holdings Shares Rose 20.9% This Week

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Organigram Global

OGI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Organigram Global Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About OGI

What is the current price of Organigram Global?

What is the 52-week range for Organigram Global?

How much debt does Organigram Global have?

How much cash does Organigram Global have on hand?

What is Organigram Global’s dividend yield?

Premium Investing Services